Suzumura N
Second Department of Surgery, Osaka University Medical School, Japan.
Nihon Geka Gakkai Zasshi. 1989 Jun;90(6):847-54.
Coagulation disorders have been noted during orthotopic liver transplantation (OLT) especially just after reperfusion of the grafted liver. This study was undertaken to clarify the coagulation disorders following reperfusion of the liver graft. OLT was carried out in adult mongrel dogs using a cuff technique. Fresh and 24-hour preserved livers were grafted. Platelet count (P1), activated partial thromboplastin time (A-PTT), prothrombin time (PT) and plasma fibrinogen levels (Fng) were measured before and after OLT. Next perfusate obtained from fresh livers or preserved livers for 24-hours or 48-hours was determined for their ability of inducing coagulation disorders when infused in untreated dogs, and was also tested for their activity of platelet aggregation, tissue thromboplastin (F-III), and plasminogen activator (PA). All dogs which received preserved livers showed a marked coagulation disorders including a decrease in P1 and Fng, and prolongation of A-PTT and PT, but the dogs with fresh liver grafts did not. Infusion of the perfusate collected from a perfusion of the preserved liver induced similar coagulation disorders in untreated dogs. The perfusate obtained from the preserved liver showed significant increased F-III activity as compared with that from fresh liver. On the other hand, neither direct platelet aggregation activity nor PA activity was seen or very low if any. These results indicate that F-III liberated from a damaged liver is responsible for the coagulation disorders after reperfusion of the graft in liver transplantation.
在原位肝移植(OLT)过程中,尤其是在移植肝脏再灌注后不久,已注意到凝血障碍。本研究旨在阐明肝移植再灌注后的凝血障碍。采用袖套技术在成年杂种犬中进行OLT。移植新鲜肝脏和保存24小时的肝脏。在OLT前后测量血小板计数(P1)、活化部分凝血活酶时间(A-PTT)、凝血酶原时间(PT)和血浆纤维蛋白原水平(Fng)。接下来,测定从新鲜肝脏或保存24小时或48小时的肝脏中获得的灌注液在注入未处理的犬时诱导凝血障碍的能力,并测试其血小板聚集活性、组织凝血活酶(F-III)和纤溶酶原激活剂(PA)的活性。所有接受保存肝脏的犬均出现明显的凝血障碍,包括P1和Fng降低,以及A-PTT和PT延长,但接受新鲜肝脏移植的犬未出现。注入从保存肝脏灌注中收集的灌注液会在未处理的犬中诱导类似的凝血障碍。与新鲜肝脏相比,从保存肝脏获得的灌注液显示F-III活性显著增加。另一方面,未观察到直接的血小板聚集活性,或者即使有也非常低。这些结果表明,从受损肝脏释放的F-III是肝移植中移植肝脏再灌注后凝血障碍的原因。